| 日付 |
時間 |
ソース |
タイトル |
|---|
| 2024/4/30 | 21:30 | PRNUS | NRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising.. |
| 2024/4/18 | 21:32 | PRNUS | NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from.. |
| 2024/4/18 | 21:30 | PRNUS | NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million.. |
| 2024/4/18 | 05:45 | PRNUS | NRx Pharmaceuticals, Inc. Announces Proposed Underwritten.. |
| 2024/4/17 | 21:30 | PRNUS | NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data.. |
| 2024/4/15 | 21:30 | PRNUS | NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of.. |
| 2024/4/08 | 21:30 | PRNUS | NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of.. |
| 2024/4/01 | 21:28 | PRNUS | NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and.. |
| 2024/3/28 | 21:03 | PRNUS | NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth.. |
| 2024/3/28 | 21:00 | PRNUS | NRx Pharmaceuticals Announces Reverse Stock Split to.. |
| 2024/3/27 | 05:03 | PRNUS | UPDATE: NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth.. |
| 2024/3/25 | 21:30 | PRNUS | NRx Pharmaceutical's (NASDAQ:NRXP) Chairman Dr. Jonathan.. |
| 2024/3/22 | 05:02 | PRNUS | NRx Pharmaceuticals to Report Fourth Quarter and Full Year.. |
| 2024/3/22 | 02:57 | PRNUS | NRx Pharmaceuticals Announces Results of the Vote Held.. |
| 2024/3/12 | 20:49 | PRNUS | NRx Pharmaceuticals (NASDAQ:NRXP) Initiates Strategy to.. |
| 2024/3/12 | 06:16 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
| 2024/3/11 | 21:30 | PRNUS | NRx Pharmaceuticals (NASDAQ:NRXP) Completes Memorandum of.. |
| 2024/3/07 | 06:08 | EDGAR2 | Form 8-K - Current report |
| 2024/3/04 | 22:30 | PRNUS | NRx Pharmaceuticals (NASDAQ: NRXP) Announces Last Patient,.. |
| 2024/3/01 | 22:30 | PRNUS | NRx Pharmaceuticals Announces Definitive Purchase Agreement.. |
| 2024/2/29 | 07:09 | EDGAR2 | Form 8-K - Current report |
| 2024/2/29 | 00:40 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 2024/2/28 | 00:49 | PRNUS | /C O R R E C T I O N -- NRx Pharmaceuticals, Inc./ |
| 2024/2/27 | 22:54 | PRNUS | NRx Pharmaceuticals, Inc. Announces Pricing of $1.5 Million.. |
| 2024/2/27 | 07:15 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 2024/2/27 | 06:01 | PRNUS | NRx Pharmaceuticals, Inc. Announces Proposed Underwritten.. |
| 2024/2/26 | 22:30 | PRNUS | NRx Pharmaceuticals (Nasdaq:NRXP) Launches HOPE.. |
| 2024/2/20 | 22:30 | PRNUS | NRx Pharmaceuticals (Nasdaq:NRXP) to Launch HOPE.. |
| 2024/2/15 | 06:30 | EDGAR2 | Form 8-K - Current report |
| 2024/2/14 | 20:03 | EDGAR2 | Form 8-K - Current report |
| 2024/2/12 | 22:30 | PRNUS | NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Advance.. |
| 2024/2/09 | 22:30 | PRNUS | NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Reports Comments by.. |
| 2024/2/05 | 20:48 | PRNUS | NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces the.. |
| 2024/2/03 | 06:37 | EDGAR2 | Form 8-K - Current report |
| 2024/1/24 | 06:16 | EDGAR2 | Form 8-K - Current report |
| 2024/1/22 | 20:48 | PRNUS | NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces.. |
| 2024/1/17 | 20:48 | PRNUS | NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Receipt.. |
| 2024/1/17 | 08:36 | EDGAR2 | Form 3 - Initial statement of beneficial ownership of.. |
| 2024/1/16 | 21:25 | DJN | NRx Pharmaceuticals Gets Fast-Track Designation for NRX-101.. |
| 2024/1/16 | 20:48 | PRNUS | NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces FDA.. |
| 2024/1/02 | 22:45 | PRNUS | NRx Pharmaceuticals (Nasdaq: NRXP) to Present Keynote.. |
| 2024/1/02 | 20:48 | PRNUS | NRx Pharmaceuticals (Nasdaq: NRXP) Demonstrates Compliance.. |
| 2023/12/30 | 06:30 | EDGAR2 | Form PRE 14A - Other preliminary proxy statements |
| 2023/12/30 | 06:15 | EDGAR2 | Form 8-K - Current report |
| 2023/12/27 | 20:48 | PRNUS | NRx Pharmaceuticals Announces the Election of Janet.. |
| 2023/12/22 | 06:05 | EDGAR2 | Form 8-K - Current report |
| 2023/12/19 | 22:15 | PRNUS | NRx Pharmaceuticals Announces Signing of a Data and.. |
| 2023/12/18 | 20:48 | PRNUS | NRx Pharmaceuticals Announces FDA Clearance of its.. |
| 2023/12/14 | 06:02 | PRNUS | NRx Pharmaceuticals Provides Notice of Annual Meeting of.. |
| 2023/12/11 | 20:48 | PRNUS | NRx Pharmaceuticals to Participate in LifeSci Corporate.. |
Hot Features
プレミアム
ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
